| # | Side effect | Count |
|---|---|---|
| 0 | NO ADVERSE EVENT | 68 |
| 1 | DEVICE DELIVERY SYSTEM ISSUE | 43 |
| 2 | DEVICE MALFUNCTION | 14 |
| 3 | DRUG INEFFECTIVE | 13 |
| 4 | PRODUCT SUBSTITUTION ISSUE | 13 |
| 5 | PRODUCT QUALITY ISSUE | 12 |
| 6 | DRUG DOSE OMISSION BY DEVICE | 10 |
| 7 | INCORRECT DOSE ADMINISTERED BY DEVICE | 8 |
| 8 | BLOOD TESTOSTERONE DECREASED | 7 |
| 9 | PRODUCT DOSE OMISSION ISSUE | 6 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | MANUFACTURING PROCESS CONTROL PROCEDURE ISSUE | 1 | 0.0455 |
| 1 | DERMAL ABSORPTION IMPAIRED | 2 | 0.0128 |
| 2 | DEVICE DELIVERY SYSTEM ISSUE | 43 | 0.0081 |
| 3 | MALABSORPTION FROM ADMINISTRATION SITE | 1 | 0.0058 |
| 4 | INCORRECT DOSE ADMINISTERED BY PRODUCT | 3 | 0.0046 |
| 5 | DEVICE INEFFECTIVE | 3 | 0.0038 |
| 6 | PRODUCT DESIGN ISSUE | 1 | 0.0037 |
| 7 | ORGANIC ERECTILE DYSFUNCTION | 1 | 0.0030 |
| 8 | DISTURBANCE IN SEXUAL AROUSAL | 2 | 0.0029 |
| 9 | DRUG DELIVERY SYSTEM ISSUE | 2 | 0.0024 |